LeMaitre Vascular (LMAT) News Today

LeMaitre Vascular, Inc. (NASDAQ:LMAT) investors are reacting to several analyst updates and corporate actions.

• Positive Sentiment: Roth Capital raised its Q2 2026 EPS estimate for LeMaitre Vascular from $0.62 to $0.63 per share, reflecting higher expected procedure volumes and strengthening margins. Q2 EPS Estimate for LeMaitre Vascular Lifted by Analyst
• Positive Sentiment: Barrington Research boosted its Q3 2025 EPS forecast for LMAT to $0.57 from $0.56 and upgraded the shares from “Market Perform” to “Outperform,” assigning a $95 price target. Stock Rating Upgraded by Barrington Research
• Positive Sentiment: LeMaitre Vascular shares gapped up following better‐than‐expected Q2 earnings, driven by above‐consensus revenue growth and margin expansion. Shares Gap Up Following Better-Than-Expected Earnings
• Neutral Sentiment: The company declared a quarterly dividend of $0.20 per share, payable September 4 to holders of record August 21, representing a 0.9% yield. Declares Quarterly Dividend of $0.20
• Neutral Sentiment: Cantor Fitzgerald lifted its price target on LMAT from $92 to $95 but maintained a “Neutral” rating, citing steady procedure volumes. Cantor Fitzgerald Issues Positive Forecast